Report persistent symptoms to your healthcare provider
That is 31 to 33 pounds lost
Your body already makes this hormone, but now youve got the power to boost it to help curb cravings & appetite
However, because retatrutide has the additional glucagon receptor component, starting at a lower-than-expected dose and titrating up remains the safest approach
The results, which were published in the Lancet on Thursday, are very encouraging for the safety and efficacy of orforglipron in people with type 2 diabetes, says Daniel Drucker, an endocrinologist at the University of Toronto, adding that he is awaiting further clinical trial results of the drug in people with obesity
This reassurance encourages clients to stay committed, knowing progress is both safe and effective